In conclusion, only the lipid nanoparticles prepared with CP and containing AO presented a stable and effective system, acting against one of the causative agents of cutaneous leishmaniasis in concentrations that do not display toxicity fibroblast and keratinocyte cells. This evidence concerns the gene CP and cutaneous leishmaniasis.